Related Experiment Video
Updated: May 24, 2026
11:44
Long Term Intravital Multiphoton Microscopy Imaging of Immune Cells in Healthy and Diseased Liver Using CXCR6.Gfp Reporter Mice
Published on: March 24, 2015
Granulomatous liver diseases: a review
Marcy Coash1, Faripour Forouhar, Catherine H Wu
1Department of Medicine, Division of Gastroenterology-Hepatology, University of Connecticut Health Center, Farmington, Connecticut 06030, USA.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|February 16, 2012
Summary
Granulomas, collections of immune cells in the liver, arise from various triggers. Understanding their causes, presentation, and management is key for diagnosing and treating these hepatic conditions.
Area of Science:
- Hepatology
- Immunology
- Pathology
Background:
- Granulomas are common in the liver, resulting from immune system stimulation by diverse agents.
- Hepatic granulomatous reactions can stem from systemic diseases or primary liver issues.
- Their clinical presentation varies significantly based on the underlying etiology.
Purpose of the Study:
- To comprehensively review the causes, presentation, and histopathology of hepatic granulomatous diseases.
- To outline the variable manifestations associated with different granulomatous conditions in the liver.
- To discuss current diagnostic and management strategies for liver granulomas.
Main Methods:
- Literature review of granulomatous liver diseases.
- Analysis of clinical presentations and histopathological findings.
- Synthesis of diagnostic and therapeutic approaches.
Main Results:
- Identified common agents and conditions leading to hepatic granulomas.
- Detailed the spectrum of clinical and histopathological manifestations.
- Summarized effective diagnostic workups and treatment options.
Conclusions:
- Hepatic granulomas necessitate a thorough etiological investigation due to varied causes.
- Accurate diagnosis relies on integrating clinical, histopathological, and etiological data.
- Tailored management strategies are crucial for optimizing patient outcomes in granulomatous liver disease.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:27Liver Histology
The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
Hepatocytes perform a variety of essential functions. They secrete...